retatrutide availability FDA Approval Status 2026: Everything We Know So Far What retatrutide when will it
Description
GLP-1 medical weight loss is designed to support appetite control and metabolic health while helping patients build sustainable habits for lasting weight management
The continuous action differs from older diabetes medications that only work for short periods
Common side effects include nausea, vomiting, diarrhoea, and constipation, usually diminishing over time
Pricing dramatically below market average is the most obvious red flag
When retatrutide continuously activates GLP-1 receptors on sensory neurons, those neurons can become "trained" to fire more easily, lowering the threshold for what triggers a sensory response
